ASB6 and colorectal cancer: Subsequent survival analysis of ASB6 copy number alteration (CNA) subgroups (Amp, Dele and WT) in colorectal cancer patients revealed that patients with ASB6 copy number amplification (Amp) had worse OS, DSS and DFI compared to those with wild-type (WT) and deletion (Dele) ASB6 (Figure 6E-G).